You are here

Results of Round 1 National Blood Sector Research and Development Pilot

The NBA was impressed with the number and quality of submissions for Round 1. The NBA’s new grant assessment process ran smoothly and has provided important information to support improvements for Round 2. The NBA was grateful to have received high quality input from clinical, research and government experts who participated in the review process and assisted the NBA in determining the mix of projects to be funded within the limited pilot budget. The NBA is confident that the funded research will provide significant inroads towards achievement of the blood sector’s research outcomes. An overview of the successful applications is presented below:

PBM Project Grants

Principal Chief Investigator

Administering Institution

Amount

Scientific Project Title

Professor Jane Ford

The University of Sydney

$146,300

Determination of 1) the haemoglobin (Hb) and ferritin levels during pregnancy associated with adverse
outcomes and 2) transfusion effects on patient-centred outcomes.

PBM Seed Grants

Principal Chief Investigator

Administering Institution

Amount

Scientific Project Title

For geriatric patients presenting to the Emergency Department, how much blood is used; why is blood used
and can we reduce red cell use and improve outcomes?

Dr Deborah Long

Griffith University

$49,162

Evaluation of a closed loop-blood sampling system in critically ill children undergoing cardiac surgery: a pilot randomised controlled trial.

PBM Early Career Research Grant (Scholarship)

Early Career Researcher

Administering Institution

Amount

Scientific Project Title

Dr Julie Lee

The University of Queensland

$30,000

ROTEM® thromboelastometry in obstetrics

Ig Project Grants

Principal Chief Investigator

Administering Institution

Amount

Scientific Project Title

Professor David Burgner

Murdoch Childrens Research Institute

$246,645

A national study of Kawasaki Disease epidemiology and management: a combined retrospective and prospective study of incidence and immunoglobulin resource utilisation to guide appropriate cost-effective management.

Associate Professor Erica Woods

Monash University

$394,958

The RATIONAL project: A feasibility trial of the role of prophylactic antibiotics or intravenous immunoglobulin to prevent infections in patients with haematologic malignancies to inform a phase III randomised controlled study, and supported by a systematic review and survey of ‘real world’ current Australasian and international practice.